The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global COVID-19 Diagnostic Testing Market Research Report 2024
Synopsis
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
The global COVID-19 Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Testing.
Report Scope
The COVID-19 Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Nucleic Acid Testing
Antibody Testing
Segment by Application
Hospitals
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
The global COVID-19 Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Testing.
Report Scope
The COVID-19 Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Nucleic Acid Testing
Antibody Testing
Segment by Application
Hospitals
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2019-2030)
2.2 COVID-19 Diagnostic Testing Growth Trends by Region
2.2.1 Global COVID-19 Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COVID-19 Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 COVID-19 Diagnostic Testing Market Dynamics
2.3.1 COVID-19 Diagnostic Testing Industry Trends
2.3.2 COVID-19 Diagnostic Testing Market Drivers
2.3.3 COVID-19 Diagnostic Testing Market Challenges
2.3.4 COVID-19 Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnostic Testing Players by Revenue
3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2023
3.5 COVID-19 Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 COVID-19 Diagnostic Testing Breakdown Data by Application
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2019-2030)
6.2 North America COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2019-2030)
7.2 Europe COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific COVID-19 Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COVID-19 Diagnostic Testing Market Size (2019-2030)
9.2 Latin America COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa COVID-19 Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Detail
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Detail
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Detail
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Detail
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Detail
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Detail
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Detail
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Detail
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Detail
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Detail
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Detail
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
11.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.17.5 ADVAITE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
